Skip to main content
Share via Share via Share via Copy link

Browne Jacobson advises shareholders on sale of lab equipment distributor business Medline Scientific to global life science provider

Browne Jacobson’s award-winning corporate dealmakers have advised the shareholders of Medline Scientific on its sale to diversified global provider of life science reagents, tools, instruments and other consumables, Calibre Scientific for undisclosed consideration.

19 January 2022

Browne Jacobson’s award-winning corporate dealmakers have advised the shareholders of Medline Scientific on its sale to diversified global provider of life science reagents, tools, instruments and other consumables, Calibre Scientific for undisclosed consideration.

Browne Jacobson senior associate, Joel Nixon who is based in the firm’s Birmingham office led on the transaction with the support of Manchester based associate Bethany Pickup.

Established over 30 years ago, Medline Scientific is one of the UK’s leading independent distributors of laboratory products and equipment. Its diverse client base is made up of UK and international institutions and organisations that cut across various markets including clinical, life science, industrial and research.

Calibre Scientific which is based in Los Angeles, California has a global client portfolio that extends across 175 countries.

Mark Duffy, Founder of Medline Scientific said: “I am delighted to partner with Calibre Scientific - their vision aligns perfectly with ours, as does their overall growth strategy in the UK distribution market and beyond. Calibre Scientific is a great platform with the resources to take Medline to the next level, and I’m very excited to see what the future brings for Medline, as part of Calibre Scientific.

“I also want to thank the Browne Jacobson team for their support on this key business move. Their expertise in the sector and in the corporate finance space is spot on and they gave us strategically focused high-quality advice throughout, ensuring the transaction went smoothly for all parties involved.”

Joel Nixon added: “We are delighted to have advised Mark and the other shareholders on this sale which enables them to work with Calibre Scientific to accelerate the further growth of the business and open up new income streams on a global level. The transaction demonstrates our corporate finance credentials in the health tech, medical device and consumable space at an international level. 

Browne Jacobson’s national corporate finance practice is ranked by Experian as one of the country’s leading corporate finance teams, with over 30 corporate and banking & finance expert lawyers delivering complex layered corporate and banking transactions. The team advises domestic and international companies from fast growing start-ups to blue chip corporations on all stages of the business life cycle from capital and finance raising, through to mergers and acquisitions, and ultimately to succession or exit planning with particular expertise in the private equity market.

Contact

Contact

Henrietta Scott

Head of Marketing

PRTeam@brownejacobson.com

+44 (0)330 045 2299

View profile
Can we help you? Contact Henrietta

Related expertise

You may be interested in...